AHA-supported bill would improve access to opioid use disorder treatment
The AHA yesterday voiced support for the Opioid Treatment Access Act (H.R. 6279), bipartisan legislation that would take steps to facilitate patients’ access to methadone treatment for opioid use disorder. The bill would direct the Substance Abuse and Mental Health Services Administration to study the impact of certain flexibilities implemented during the COVID-19 public health emergency to enhance access to methadone treatment services and reduce stigma; allow patients to receive one-month supplies of methadone after two years of continuous treatment; permit pharmacies to dispense methadone; and codify regulations that allow opioid treatment programs to operate mobile medication components without separate registration.
Related News Articles
Perspective
Congressional lawmakers are heading home for a two-week district work period after both the Senate and House passed a revised budget resolution for fiscal year…
Headline
Story Updated April 5 at 8:30 a.m. ETThe Senate by a vote of 51 to 48 passed its revised budget resolution for fiscal year 2025 with Sens. Rand…
Headline
The AHA and dozens of other organizations yesterday urged House and Senate sponsors of the Conrad State 30 and Physician Access Reauthorization Act to…
Headline
The AHA March 27 voiced opposition to the Physician Led and Rural Access to Quality Care Act (H.R. 2191), a bill that would lift the ban on the establishment…
Headline
The AHA March 11 shared ways Congress could better support patient access to post-acute care in comments for a hearing held by the House Committee on Ways and…
Headline
The House of Representatives March 11 voted 217-213 to pass a continuing resolution to fund the federal government through Sept. 30. The bill also extends…